Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Study identifies Apex1 as a redox-regulated driver of fracture repair February 2, 2026 DASH diet may help preserve cognitive function in women later in life October 20, 2023 Surprising risks found in popular cinnamon brands across Europe July 7, 2025